Cite
Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis.
MLA
Movahedi, Mohammad, et al. “Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis.” Arthritis & Rheumatology, vol. 68, no. 5, May 2016, pp. 1089–98. EBSCOhost, https://doi.org/10.1002/art.39537.
APA
Movahedi, M., Beauchamp, M., Abrahamowicz, M., Ray, D. W., Michaud, K., Pedro, S., & Dixon, W. G. (2016). Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology, 68(5), 1089–1098. https://doi.org/10.1002/art.39537
Chicago
Movahedi, Mohammad, Marie‐Eve Beauchamp, Michal Abrahamowicz, David W. Ray, Kaleb Michaud, Sofia Pedro, and William G. Dixon. 2016. “Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis.” Arthritis & Rheumatology 68 (5): 1089–98. doi:10.1002/art.39537.